Tips & Guidelines

Omnipod 5 is the first automated insulin delivery system (AID) FDA cleared for patients with type 2 diabetes in the US. It is also the first and only tubeless AID system in the US. A single arm, multicenter prospective study by Pasquel et al.

The American Diabetes Association’s (ADA) new guideline changes signify stronger recommendations for insulin pump therapies than in the past and recognize their benefits in patients with insulin-requiring type 2 diabetes (T2D).

Diabetes impacts your patients’ daily lives in countless ways, adding complexity and additional considerations to all daily decisions, including at mealtimes. Counting carbohydrates (carbs) or calculating how much insulin to give at mealtimes can be challenging.

As clinicians, our intention is to provide quality patient care and education to people living with diabetes. However, upon diagnosis, we tend to impart a deluge of “new and critical” information all at once.

As clinicians who care for and counsel people with diabetes, we’ve become familiar with the concepts of delivering person-centered care and using shared decision-making.

The author has been compensated for this article.